Quality Assurance Manager
in health
A Quality Assurance Manager owns the quality system and holds the authority to say what is good enough to release and what gets held.
A Quality Assurance (QA) Manager owns the quality system that decides whether an organisation can consistently release, operate, and improve its products and services without compromising safety, integrity, or trust. They sit at the point where delivery meets accountability: their job is to make sure quality is a measurable governed outcome, not a slogan or a final test phase. They are the person with the authority to say what is good enough to release, and to hold or stop the rest.
In plain terms, a QA Manager owns the standards, the evidence, the controls, and the decisions that make quality repeatable under pressure. Across health and life sciences that work shows up in different settings. In a digital health or HealthTech company it looks like release gates, defect severity calls, and incident response on software that touches clinical decisions and sensitive health data. In pharma, biotech, and the contract research organisations (CROs) that support them it looks like GxP and GCP quality systems, document control, deviation and CAPA management, and audit readiness. In a medical devices or diagnostics firm it sits alongside ISO 13485 and design controls. In an NHS trust or private healthcare provider it leans towards clinical governance, audit, and assurance of services. The setting changes the vocabulary. The core accountability does not.
More than anything, a QA Manager is accountable for the quality system around the product: the framework that prevents avoidable harm, survives team changes and growth, and produces evidence that holds up when a regulator, an auditor, or a customer comes to look.
How this role differs in health and life sciences
In many software industries QA is framed as a delivery function: optimise pipelines, raise coverage, reduce regressions, ship faster. In health and life sciences QA is closer to a risk-management leadership role. The same defect severity scale shifts the moment the product influences real clinical workflows, handles patient data, supports regulated claims, or feeds a diagnosis. A problem that would be a minor inconvenience elsewhere can become a patient-safety event, a reportable incident, or an audit finding here.
QA Managers in this sector operate with tighter constraints and a longer memory. You cannot lean on "we will fix it next sprint" when the issue could affect continuity of care, data integrity, or inspection readiness. Decisions are shaped by traceability expectations, the maturity of incident response, and the need to demonstrate control rather than just achieve a one-off outcome.
The frameworks differ by setting. A digital health QA Manager works to clinical risk standards (DCB0129 and DCB0160), data protection expectations, and the assurance NHS and CQC-regulated buyers ask for before they will deploy. A QA Manager in pharma, biotech, or a CRO lives in GxP and GCP, where good clinical practice, the role of the MHRA and the HRA, and documented evidence are not optional. In medical devices and diagnostics, ISO 13485 and design controls shape the system. The constant across all of them is the same: once something is released into care, you cannot quietly patch your way out of harm that has already happened.
The result is a role with a different centre of gravity: less about tools and testing tactics, more about governance, evidence, cross-functional decision-making, and knowing when acceptable risk is genuinely acceptable.
Core responsibilities in health and life sciences
Day to day, a QA Manager is accountable for the reality behind the release notes: whether changes were built and verified in a way that can be defended, repeated, and trusted. They translate broad expectations (safe care, privacy, reliability, compliance) into concrete quality gates and decision forums that product, engineering, clinical, regulatory, and operations can actually follow. Expect to:
- Own release and acceptance decisions, with the authority to block, delay, or constrain a release when the evidence is insufficient.
- Define and run the quality system: the standards, procedures, records, training, and governance that make quality repeatable rather than dependent on who happens to be on shift.
- Lead deviation, nonconformance, and incident handling, then shape corrective and preventive actions (CAPA) that actually stop the problem recurring.
- Hold continuous audit and inspection readiness for MHRA, notified body, customer, or internal audits, demonstrating that the system is followed and effective, not just written down.
- Make trade-offs explicit when delivery pressure and assurance are in tension, turning risk into concrete options the right people can decide on.
- Own supplier and third-party quality where the organisation depends on outside parties, from CROs to software vendors to manufacturers.
- Translate quality risk into plain operational and commercial language for leadership, so go and no-go calls are informed rather than hopeful.
A release might improve the user experience but introduce uncertainty in a critical workflow. A hotfix might reduce harm quickly while creating documentation debt that becomes dangerous later. The QA Manager makes sure those decisions are deliberate, with the right people in the room, the right evidence captured, and the right mitigations in place. In mature organisations they also influence complaint handling and the operational quality signals that sit beyond pure software testing, because real-world outcomes depend on the whole system, not just the code.
Skills and competencies for health and life sciences
| Core skill | What it looks like in health and life sciences | Why it matters |
|---|---|---|
| Risk-based judgement | Calibrating quality controls to clinical and operational criticality rather than raw defect counts | Prevents both under-control (unsafe releases) and over-control (paralysed delivery) by aligning effort to real patient and service risk |
| Release authority | Confidence to block, delay, or constrain a release when the evidence is thin | Protects patients and customers from hope-driven launches and forces the organisation to treat quality evidence as non-negotiable |
| Quality-system thinking | Understanding how processes, records, training, and governance create repeatable quality under audit and incident pressure | Ensures quality survives team changes, growth, and outages because it is built into how work happens |
| Regulatory fluency | Working knowledge of the frameworks for the setting: GxP and GCP, ISO 13485, DCB0129 and DCB0160, and MHRA and HRA expectations | Keeps the quality system aligned with the route to market and avoids costly findings at audit or inspection |
| Cross-functional leadership | Aligning engineering, product, clinical and regulatory colleagues, and operations around shared acceptance criteria | Avoids QA versus delivery dynamics and turns quality into a joint responsibility with clear accountability |
| Evidence discipline | Knowing what to document, how much, and how to keep records usable rather than performative | Produces defensible assurance without drowning teams in paperwork and speeds up investigations when incidents occur |
| Incident learning and CAPA | Turning production issues, complaints, and near-misses into systemic fixes with tracked follow-through | Reduces repeat failures and builds trust by showing control, transparency, and measurable improvement |
| Communication under pressure | Clear precise explanation of risk, impact, and mitigations to non-technical audiences | Helps leaders make informed go and no-go calls and prevents damage caused by vague or minimising narratives |
Salary ranges in UK health and life sciences
QA Manager pay follows accountability more than job title. Compensation moves with the criticality of the product (clinical impact and reliance on the service), the depth of assurance expected (governance, evidence, audit and inspection readiness), the scope of ownership (single team versus multi-product, suppliers, operational quality), and the intensity of the release and incident cadence. Location matters, but it is often secondary to how close to patient impact the role sits and how much authority the person is expected to exercise. Pharma, biotech, and device employers tend to pay above generic software QA for the same level because the regulated stakes are higher.
| Experience level | Estimated annual salary range | What drives compensation |
|---|---|---|
| Junior | London & South East: £36,000 to £46,000. Rest of UK: £32,000 to £42,000 | Supporting a QA programme with limited release authority; pay rises with exposure to regulated constraints, incident participation, and ownership of a defined quality area |
| Mid-level | London & South East: £46,000 to £62,000. Rest of UK: £42,000 to £56,000 | Owning quality for a product area or squad; pay varies with responsibility for assurance evidence, GxP or clinical risk exposure, and influence over go and no-go decisions |
| Senior | London & South East: £62,000 to £82,000. Rest of UK: £55,000 to £74,000 | Broad ownership across teams, higher-stakes releases, incident leadership, supplier and third-party assurance, and an expectation to shape governance rather than follow it |
| Lead | London & South East: £80,000 to £100,000. Rest of UK: £70,000 to £92,000 | Accountable for quality strategy across multiple teams or products, leading audits and assessments, standardising controls, and holding firm release authority |
| Head / Director | London & South East: £100,000 to £135,000. Rest of UK: £90,000 to £120,000 | Enterprise-wide quality accountability, executive stakeholder management, budgets and hiring, multi-supplier risk, and responsibility for whether the organisation can scale without losing control |
Sources: SalaryExpert UK (2026 average around £68,000) and Glassdoor UK for QA manager, pharmaceutical GMP and GxP quality manager, and quality and regulatory roles in medical devices and pharma (2025 to 2026). Treat these as a guide; real offers move with employer, setting and specialism.
Beyond base salary, total compensation commonly includes a performance bonus (often tied to company and delivery goals), pension, private healthcare, and, more often in venture-backed digital health and biotech, equity options that can materially change the total. On-call is not universal for QA Managers, but it can appear when the role is tightly coupled to release control, incident response leadership, or regulated operational assurance. Pay shifts upward with higher incident intensity, broader scope, and stronger personal accountability for go and no-go decisions.
Career pathways
Most QA Managers reach the role through one of three realistic routes: software QA and testing then expanding into governance; operational quality or compliance roles (GxP, clinical audit, document control) moving closer to product delivery; or an engineering, product, or clinical background where the person becomes the quality owner and formalises that responsibility. Early progression tends to come from owning a slice of quality end to end, such as release readiness, incident learning, supplier assurance, or evidence management, rather than accumulating more test execution.
Over time, responsibility widens from "is this feature ready?" to "is this product safe and controlled at scale?" Senior QA Managers are trusted to define quality gates, escalate risk, and enforce corrective action without leaning on hierarchy. Lead and Head or Director progression comes from building durable systems: scalable governance, predictable audits and inspections, measurable quality signals, and a culture where quality is shared but accountability is clear. Adjacent moves into regulatory affairs, clinical governance, or broader operations leadership are common.
The strongest pathway is not more certificates or more tools. It is credible decision-making: being the person leadership trusts to protect patients and keep delivery moving with defensible documented judgement.
FAQ
Do QA Managers still do hands-on testing or is it mainly governance?
It depends on team size and maturity. In smaller companies QA Managers often stay close to hands-on assurance while also owning processes and release decisions. In larger organisations the role shifts towards governance, evidence quality, and cross-team risk decisions, with hands-on work delegated to QA engineers or embedded teams.
How do employers assess QA Managers during interviews?
Expect scenario-based evaluation: releasing under uncertainty, handling a high-severity incident, or deciding how much evidence is enough when timelines are tight. Strong candidates explain the trade-offs, who they would involve, what they would document, and how they would prevent recurrence, without defaulting to tool-led answers. In regulated settings you may also be asked how you would prepare for and handle an MHRA inspection or a customer audit.
Will I be expected to be on-call as a QA Manager?
Not always, but you may be expected to take part in incident response, especially if you own release gates or operational assurance. Where on-call exists it is usually driven by production criticality and how central QA is to go and no-go decisions and post-incident corrective action. Clarify expectations early: frequency, compensation, and whether you are the decision-maker or a supporting responder.
Find your next role
Ready to take on quality ownership where the stakes are real? Search Quality Assurance Manager roles on Meeveem and find a scope that matches your level of accountability.